Bluejay Share Price

Bluejay Share Price

NASDAQ: BJDX | Micro Cap | Healthcare
$1.74
+$1.74 (--%) Last updated on 21 Nov, 2026 | 02:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Bluejay Stock Performance

Open
$1.71
Prev. Close
N/A
Circuit Range
N/A
Day Range
$1.71 - $1.74
Year Range
$0.48 - $6.99
Volume
286
Average Traded
$1.72

Bluejay Share Price Chart

Line chart of the Bluejay price trend over the selected period. The price rose overall, ranging from 1.71 to 1.84, ending at 1.74.
$1.71$1.74
L
Show Current Price
H

Bluejay Stock Fundamentals & Key Indicators

Market Cap
$781334.82
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-6.88
Revenue (TTM)
$0.00
Return On Equity (TTM)
-103.28%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-40.56%

Bluejay Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.43-$1.92-$2.32-$2.01
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-34.27%-20.83%13.36%

Bluejay Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.25$0.00$0.00$0.00
Net Profit-$9.30-$9.95-$20.94-$6.85
Net Profit Margin-3720.00%N/AN/AN/A
Income ChangeN/A-6.99%-110.45%67.29%

Bluejay Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.661.761.651.73
Current Assets5.464.93.2211.79
Total Assets7.126.664.8713.52
Non Current Liabilities0.020.120.20.34
Current Liabilities1.120.811.771.64
Total Liabilities1.140.931.971.98
Shareholders' Equity5.985.732.8911.54

Bluejay Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-6.05-7.82-8.31-7.74
Investing-0.17-0.31-0.7-1.2
Financing7.0910.221.110.01

Corporate Actions

Split
Ex-date: 03 Nov 2026

Split
Ex-date: 29 Jan 2026

Split
Ex-date: 18 Nov 2024

Split
Ex-date: 20 Jun 2024

Split
Ex-date: 24 Jul 2023

About Bluejay

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Bluejay Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.52
$1.74
+264.02%
Oct 2026
$0.85
$0.48
-43.10%
Sep 2026
$0.82
$0.84
-7.59%
Aug 2026
$0.89
$0.91
+2.13%
Jul 2026
$1.14
$0.89
-25.21%
Jun 2026
$2.08
$1.19
-43.87%
May 2026
$1.85
$2.12
+18.44%
Apr 2026
$1.93
$1.79
+0.56%
Mar 2026
$2.01
$1.78
-11.40%
Feb 2026
$3.32
$2.01
-43.41%
Jan 2026
$0.65
$3.55
+425.15%
Dec 2025
$1.32
$0.68
-47.60%

Bluejay Share Price FAQs